International Clinical Trial: SPF of Cavin Kare BB Sunscreen SC2026105-37

Geneva, May 4 -- International Clinical Trials Registry received information related to the study (CTRI/2026/04/109324) titled 'SPF of Cavin Kare BB Sunscreen SC2026105-37' on April 24.

Study Type: PMS

Study Design: Single Arm Study Method of generating randomization sequence:Not Applicable Method of allocation concealment:Not Applicable Blinding and masking:Open Label

Primary Sponsor: CavinKare Private Limited

Intervention: Intervention1: Test Product: BB Sunscreen SC2026105-37: Quantity2 mg/sq.cm Route of administration: Topical Frequency: Once Duration: 24 hour Control Intervention1: Reference Sunscreens: Quantity2 mg/sq.cm Route of administration: Topical Frequency: Once Duration: 24 hour

Recruitment Status: Not Recruiting...